Lisa E Gralinski
Overview
Explore the profile of Lisa E Gralinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
10266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schafer A, Gralinski L, Leist S, Hampton B, Mooney M, Jensen K, et al.
Virus Res
. 2024 Mar;
344:199357.
PMID: 38508400
Coronavirus (CoV) cause considerable morbidity and mortality in humans and other mammals, as evidenced by the emergence of Severe Acute Respiratory CoV (SARS-CoV) in 2003, Middle East Respiratory CoV (MERS-CoV)...
2.
Zhou P, Song G, Liu H, Yuan M, He W, Beutler N, et al.
Immunity
. 2023 Mar;
56(3):669-686.e7.
PMID: 36889306
Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against novel pandemic coronaviruses and to more effectively respond to SARS-CoV-2 variants. The emergence of Omicron and subvariants...
3.
Conway E, Mackman N, Warren R, Wolberg A, Mosnier L, Campbell R, et al.
Nat Rev Immunol
. 2022 Aug;
22(10):639-649.
PMID: 35931818
COVID-19-associated coagulopathy (CAC) is a life-threatening complication of SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving this condition are unclear. Evidence supports the concept that CAC involves complex...
4.
Schafer A, Leist S, Gralinski L, Martinez D, Winkler E, Okuda K, et al.
mBio
. 2022 Jul;
13(4):e0145422.
PMID: 35862771
Infectious diseases have shaped the human population genetic structure, and genetic variation influences the susceptibility to many viral diseases. However, a variety of challenges have made the implementation of traditional...
5.
Dinnon 3rd K, Leist S, Okuda K, Dang H, Fritch E, Gully K, et al.
Sci Transl Med
. 2022 Jul;
14(664):eabo5070.
PMID: 35857635
A subset of individuals who recover from coronavirus disease 2019 (COVID-19) develop post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC), but the mechanistic basis of PASC-associated lung...
6.
Schafer A, Leist S, Gralinski L, Martinez D, Winkler E, Okuda K, et al.
bioRxiv
. 2022 Jun;
PMID: 35677067
Infectious diseases have shaped the human population genetic structure, and genetic variation influences the susceptibility to many viral diseases. However, a variety of challenges have made the implementation of traditional...
7.
He W, Musharrafieh R, Song G, Dueker K, Tse L, Martinez D, et al.
Nat Immunol
. 2022 Jun;
23(6):960-970.
PMID: 35654851
The emergence of current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human...
8.
Zhou P, Song G, He W, Beutler N, Tse L, Martinez D, et al.
bioRxiv
. 2022 Mar;
PMID: 35291291
Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against coronaviruses that cause severe disease, for anticipating novel pandemic-causing viruses, and to respond more effectively to SARS-CoV-2...
9.
Dinnon 3rd K, Leist S, Okuda K, Dang H, Fritch E, Gully K, et al.
bioRxiv
. 2022 Feb;
PMID: 35194605
COVID-19 survivors develop post-acute sequelae of SARS-CoV-2 (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal samples. Mouse-adapted SARS-CoV-2 MA10 produces an acute respiratory...
10.
He W, Musharrafieh R, Song G, Dueker K, Tse L, Martinez D, et al.
bioRxiv
. 2022 Feb;
PMID: 35169804
The emergence of current SARS-CoV-2 variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human health and the global economy ....